NCT04187846 is a clinical trial in Tissue Oxygenation, sponsored by Hakan Tapar.

Who is sponsoring NCT04187846?

NCT04187846 is sponsored by Hakan Tapar.

What condition does NCT04187846 study?

NCT04187846 studies Tissue Oxygenation.

Is NCT04187846 still recruiting?

NCT04187846 is currently status unknown. Last updated 5 December 2019.

Last reviewed 2019-12-05 · How we verify

NCT04187846

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postspinal Headache and Near Infrared Spectroscopy (NIRS)

Status unknown Last updated 5 December 2019

What this trial tests

trial in Tissue Oxygenation in 200 participants. Status unknown.

Timeline

15 March 2019

Primary endpoint
30 December 2019

10 March 2020

Quick facts

Lead sponsor	Hakan Tapar
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	15 March 2019
Primary completion	30 December 2019
Estimated completion	10 March 2020
Sites	1 location across Turkey (Türkiye)

Conditions studied

Tissue Oxygenation — all drugs for Tissue Oxygenation →

Sponsor

Hakan Tapar

Who can join

Adults 18 to 45, female only, with Tissue Oxygenation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the relationship between postspinal headache and near infrared spectroscopy in cesarean section patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tissue Oxygenation

Currently open trials in the same condition.

NCT07166341 — Accuracy Verification of the INVOS PM7100 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04187846 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hakan Tapar
Last refreshed: 5 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04187846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing